It's been ignored during covid. The relabelling by the FDA was really big yet unnoticed it would seem. I have really been impressed their dealings with the FDA, most small cap pharmas aren't this good at it. It really was a no BS call yesterday. Each speaker gave a solid presentation and had in depth answers to every question. Very impressive.
News 
Market Data 
Discover 
